Basic Information
GenScript ProBio, the biopharmaceutical CDMO division of GenScript, is committed to providing innovative solutions for antibody drug development, including antibody discovery, antibody engineering, and antibody characterization. In biologics development services, GenScript has established a compliant platform, ranging from stable cell line development to clinical manufacturing services, delivering high-quality materials for IND and clinical trials. GenScript ProBio’s comprehensive gene and cell therapy solutions cover CMC for plasmids and viruses used in IND filing, clinical manufacturing, and commercial manufacturing.
GenScript ProBio
NewJersey,United States of America
more than 500 people
July 01, 2020
cdmo.us@genscript.com

